Patents by Inventor Yong Ni

Yong Ni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11664794
    Abstract: The present disclosure provides a substrate-enhanced comparator and electronic device, the comparator including: a cross-coupled latch, for connecting input signals to the gate of a cross-coupled MOS transistor to form a first input of the latch; output buffers, connected to the cross-coupled latch for amplifying output signals of the latch; AC couplers, connected to the output buffers for receiving and amplifying the output signals of the latch, coupling the output signals to substrates of the cross-coupled MOS transistors to form second inputs of the latch. The cross-coupled latch is also for output signal regenerative latching based on input signals sampled at the first inputs and input signals sampled at the second inputs. The present disclosure introduces additional substrate inputs to the cross-coupled structure of the conventional latch as the second inputs of the latch.
    Type: Grant
    Filed: January 7, 2020
    Date of Patent: May 30, 2023
    Assignees: NO.24 RESEARCH INSTITUTE OF CHINA ELECTRONICS TECHNOLOGY GROUP CORPORATION, Chongqing GigaChip Technology Co., Ltd.
    Inventors: Ting Li, Zhengbo Huang, Yong Zhang, Yabo Ni, Jian'an Wang, Guangbing Chen, Dongbing Fu, Zicheng Xu
  • Publication number: 20230136579
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Application
    Filed: December 29, 2022
    Publication date: May 4, 2023
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • Patent number: 11636340
    Abstract: The present disclosure proposes a modeling method and apparatus for diagnosing an ophthalmic disease based on artificial intelligence, and a storage medium. The modeling method includes: establishing a data collection of ophthalmic images and a data collection of non-image ophthalmic disease diagnosis questionnaires; training a first neural network model by employing the data collection of the ophthalmic images to obtain a first classification model; training a second classification model by employing the data collection of non-image ophthalmic disease diagnosis questionnaires; and merging the first classification model and the second classification model to obtain a target classification network model, in which, a test result outputted by the target classification network model is used as a diagnosis result of the ophthalmic disease.
    Type: Grant
    Filed: April 17, 2018
    Date of Patent: April 25, 2023
    Assignees: BGI SHENZHEN, EYE, EAR, NOSE, AND THROAT HOSPITAL OF FUDAN UNIVERSITY
    Inventors: Xiaoqing Liu, Jiaxu Hong, Yong Ni, Shuangshuang Li, Lili Wang, Wei He, Youwen Guo, Yuxuan Liu, Yong Liu, Wei Wang, Ruiqi Xu, Jingyi Cheng, Lijia Tian, Wenbin Chen, Xun Xu
  • Patent number: 11576864
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: February 14, 2023
    Assignees: Incyte Corporation, Incyte Holdings Corporation
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • Patent number: 11576865
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Grant
    Filed: June 23, 2022
    Date of Patent: February 14, 2023
    Assignees: Incyte Corporation, Incyte Holdings Comoration
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • Publication number: 20230027628
    Abstract: Examples of the present disclosure describe systems and methods for enterprise search that leverage periodically updated user context of an enterprise user for intent understanding and treat a search session as a dialog between the user and a digital assistant to allow multi-modal interaction. For example, a query input by the user may be received from a client application having search functionality and an integrated assistant. A current state of the user context may be leveraged to understand the query. Based on the understanding, one or more responsive entities may be retrieved from an enterprise search index as results. Based on the results, a response may be generated that includes the results and a prompt to cause the user to further refine the query and/or provide feedback. The response may be provided to the client application for output as part of a search session dialog between the user and assistant.
    Type: Application
    Filed: July 26, 2021
    Publication date: January 26, 2023
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: Ming WU, Yue MA, Yong NI
  • Publication number: 20230004568
    Abstract: Examples of the present disclosure describe systems and methods for generating multiple semantic hypotheses for search query intent understanding. In aspects, a search query may be received by a query analysis component associated with a search system. The query analysis component may be used to evaluate the search query for ambiguity in the domain, intent, and/or slot(s) of the search query. A set of hypotheses representing for one or more combinations of the domain, intent, and/or slot(s) of the search query may be generated. The set of hypotheses may be scored and/or ranked. Based on the scores/ranks, one or more of the hypotheses in the set of hypotheses may be provided to a user and/or one or more processing components accessible to the search system.
    Type: Application
    Filed: June 30, 2021
    Publication date: January 5, 2023
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: Ming WU, Yong NI, Guo MEI
  • Publication number: 20220331253
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Application
    Filed: June 23, 2022
    Publication date: October 20, 2022
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • Publication number: 20220323363
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Application
    Filed: June 23, 2022
    Publication date: October 13, 2022
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • Publication number: 20220211631
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Application
    Filed: March 23, 2022
    Publication date: July 7, 2022
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • Patent number: 11337927
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: May 24, 2022
    Assignees: Incyte Holdings Corporation, Incyte Corporation
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • Patent number: 11232101
    Abstract: A method, an apparatus and a system for information retrieval are provided. The method for information retrieval may comprise: receiving a query in a natural language form from a user (210); extracting a plurality of feature vectors from the query based on a plurality of knowledge entries in a knowledge base associated with the user and a built-in featurization source, one feature vector per knowledge entry (220); obtaining, with a pre-trained language understanding model, a plurality of language understanding results based on the plurality of feature vectors (230); and selecting a knowledge entry corresponding to the query among the plurality of entries based on the plurality of language understanding results (240). The method may extract more features and combine information retrieval and language understanding in one shot to improve efficiency.
    Type: Grant
    Filed: October 10, 2016
    Date of Patent: January 25, 2022
    Assignee: Microsoft Technology Licensing, LLC
    Inventor: Yong Ni
  • Publication number: 20210128477
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Application
    Filed: November 16, 2020
    Publication date: May 6, 2021
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • Publication number: 20210035689
    Abstract: The present disclosure proposes a modeling method and apparatus for diagnosing an ophthalmic disease based on artificial intelligence, and a storage medium. The modeling method includes: establishing a data collection of ophthalmic images and a data collection of non-image ophthalmic disease diagnosis questionnaires; training a first neural network model by employing the data collection of the ophthalmic images to obtain a first classification model; training a second classification model by employing the data collection of non-image ophthalmic disease diagnosis questionnaires; and merging the first classification model and the second classification model to obtain a target classification network model, in which, a test result outputted by the target classification network model is used as a diagnosis result of the ophthalmic disease.
    Type: Application
    Filed: April 17, 2018
    Publication date: February 4, 2021
    Inventors: Xiaoqing Liu, Jiaxu Hong, Yong Ni, Shuangshuang Li, Lili Wang, Wei He, Youwen Guo, Yuxuan Liu, Yong Liu, Wei Wang, Ruiqi Xu, Jingyi Cheng, Lijia Tian, Wenbin Chen, Xun Xu
  • Patent number: 10874616
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Grant
    Filed: November 14, 2018
    Date of Patent: December 29, 2020
    Assignees: Incyte Corporation, Incyte Holdings Corporation
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • Publication number: 20190231696
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Application
    Filed: November 14, 2018
    Publication date: August 1, 2019
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • Patent number: 10356156
    Abstract: The present disclosure discloses a method and a device for loading a webpage. The method for loading a webpage includes: sending a webpage request message to a server; receiving an initial webpage of the webpage returned from the server, the initial webpage including an agent; sending a WebSocket connection request message to the server through the agent, to establish a WebSocket connection with the server; sending a page component request message of the webpage to the server based on the WebSocket connection, to load page component of the webpage; receiving the page components of the webpage returned from the server based on the WebSocket connection; and creating the page components at corresponding positions in the initial webpage.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: July 16, 2019
    Assignee: Delta Electronics (Shanghai) CO., LTD
    Inventors: Ziyu Zhu, Yong Ni, Dong Xie, Dongdong Su
  • Publication number: 20190205301
    Abstract: A method, an apparatus and a system for information retrieval are provided. The method for information retrieval may comprise: receiving a query in a natural language form from a user (210); extracting a plurality of feature vectors from the query based on a plurality of knowledge entries in a knowledge base associated with the user and a built-in featurization source, one feature vector per knowledge entry (220); obtaining, with a pre-trained language understanding model, a plurality of language understanding results based on the plurality of feature vectors (230); and selecting a knowledge entry corresponding to the query among the plurality of entries based on the plurality of language understanding results (240). The method may extract more features and combine information retrieval and language understanding in one shot to improve efficiency.
    Type: Application
    Filed: October 10, 2016
    Publication date: July 4, 2019
    Inventor: Yong Ni
  • Patent number: 10166191
    Abstract: The present invention relates to sustained-release formulations and dosage forms of ruxolitinib, or a pharmaceutically acceptable salt thereof, which are useful in the treatment of Janus kinase-associated diseases such as myeloproliferative disorders.
    Type: Grant
    Filed: November 14, 2013
    Date of Patent: January 1, 2019
    Assignees: Incyte Corporation, Incyte Holdings Corporation
    Inventors: Yong Ni, Bhavnish Parikh, Krishnaswamy Yeleswaram, Susan Erickson-Viitanen, William V. Williams
  • Patent number: 9954359
    Abstract: A power supply circuit coupled to a power source for providing electronic energy to a workload includes a first switch, a control circuit, a first diode, and a backup power, in which the input of the first switch is coupled to the power source, the output of the first switch is coupled to the workload, the control circuit is coupled to the control terminal of the first switch for determining the state of the power source, the anode of the first diode is coupled to the power source, the cathode of the first diode is coupled to the first terminal of the backup power, the first terminal of the backup power is further coupled to the workload, when the control circuit determines that the power source is in a power-off state, a control signal is applied to the control terminal of the first switch to turn off the first switch.
    Type: Grant
    Filed: July 26, 2013
    Date of Patent: April 24, 2018
    Assignee: MEMBLAZE TECHNOLOGY (BEIJING) CO., LTD.
    Inventor: Yong Ni